We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
10 Things to Know About Monoclonal Antibodies
CSL Behring made three recent announcements related to medicines known as “mabs.”
Watch Now: NBC Features CoVIg-19 Plasma Alliance
CoVIg-19 Plasma Alliance is working to develop potential treatment to fight global pandemic.
Doctor's Day 2020
We thank physicians on the front lines, battling a pandemic.
While Scientists Get To Work
Nobel Prize winners recently offered advice to young scientists – guidance that resonates as the world’s scientific community…
Women In Science Quiz
Did you know? February 11 is the International Day of Women and Girls in Science.
There She Is ... a Scientist
Miss America 2020 won the rebooted contest with an on-stage experiment.
Breaking Ground on New R&D Space in Germany
The “Cube” in Marburg will house 600 colleagues upon completion in 2022.
What You and Fall Leaves Have In Common
The ingredient that gives leaves and plasma their yellow colors.
Watching Over Product Safety
Pathogen expert Nathan Roth leads a team that takes a vigilant approach with the medicines patients rely on.
Celebrating Partnership With Penn State
CSL Behring named Penn State University’s Corporate Partner of the Year.
The 2019 Nobel Prizes and the Promise of Science
Every Nobel Prize week, we remember CSL Behring’s namesake, named a Nobel laureate in 1901.
Three Things to Know About Flu Forecasting
A data-driven approach to predicting outbreaks could be good news for at-risk patients.
Popular search terms:
Americas
Asia Pacific
Europe
